Therapy of lung cancer in China: introducing the special collection by Jiadi Gan, Wenfeng Fang, Li Zhang

Get full text

Research progress in immune checkpoint inhibitors for lung cancer in China by Jiadi Gan, Yihua Huang, Wenfeng Fang, Li Zhang

Get full text

GSK3beta is involved in JNK2-mediated beta-catenin inhibition. by Dong Hu, Xiuli Bi, Wenfeng Fang, Anjia Han, Wancai Yang

Get full text

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment by Tao Jiang, Qingzhu Jia, Wenfeng Fang, Shengxiang Ren, Xiaoxia Chen, Chunxia Su, Li Zhang, Caicun Zhou

Get full text

Evaluation of the astrometric capability of Multi-Channel Imager and simulated calculation of proper motion of M31 by Wenfeng Fang, Wenfeng Fang, Yong Yu, Yong Yu, Xiyan Peng, Zhaojun Yan, Yanzhen Hao, Yanzhen Hao, Huanyuan Shan, Zhaoxiang Qi, Zhaoxiang Qi, Shilong Liao, Shilong Liao, Zhenghong Tang, Zhenghong Tang, Qiqi Wu, Qiqi Wu, Zhensen Fu, Zhensen Fu

Get full text

Genetic Liability to Insomnia and Lung Cancer Risk: A Mendelian Randomization Analysis by Jiayi Shen, Jiayi Shen, Jiayi Shen, Jiayi Shen, Huaqiang Zhou, Huaqiang Zhou, Huaqiang Zhou, Jiaqing Liu, Jiaqing Liu, Jiaqing Liu, Yaxiong Zhang, Yaxiong Zhang, Yaxiong Zhang, Ting Zhou, Ting Zhou, Ting Zhou, Gang Chen, Gang Chen, Gang Chen, Wenfeng Fang, Wenfeng Fang, Wenfeng Fang, Yunpeng Yang, Yunpeng Yang, Yunpeng Yang, Yan Huang, Yan Huang, Yan Huang, Li Zhang, Li Zhang, Li Zhang

Get full text

A modifiable risk factors atlas of lung cancer: A Mendelian randomization study by Jiayi Shen, Huaqiang Zhou, Jiaqing Liu, Yaxiong Zhang, Ting Zhou, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang

Get full text

The ACTIVE study protocol: apatinib or placebo plus gefitinib as first-line treatment for patients with EGFR-mutant advanced non-small cell lung cancer (CTONG1706) by Zhonghan Zhang, Fan Luo, Yang Zhang, Yuxiang Ma, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang, Hongyun Zhao

Get full text

Preferable background filtering for next-generation sequencing analysis in non-small cell lung cancer: pericarcinomatous tissues or peripheral blood lymphocytes? by Yaxiong Zhang, Lianpeng Chang, Wenfeng Fang, Yunpeng Yang, Lanjun Zhang, Shaodong Hong, Huaqiang Zhou, Yanfang Guan, Xin Yi, Li Zhang

Get full text

Phase I study of camrelizumab in patients with advanced solid tumors by Yuxiang Ma, Jiaxin Cao, Yang Zhang, Qianwen Liu, Wenfeng Fang, Yunpeng Yang, Yuanyuan Zhao, Qing Yang, Hongyun Zhao, Li Zhang

Get full text

A multicenter, retrospective epidemiologic survey of the clinical features and management of bone metastatic disease in China by Yunpeng Yang, Yuxiang Ma, Jin Sheng, Yan Huang, Yuanyuan Zhao, Wenfeng Fang, Shaodong Hong, Ying Tian, Cong Xue, Li Zhang

Get full text

A protective role by interleukin-17F in colon tumorigenesis. by Zan Tong, Xuexian O Yang, Huichao Yan, Weihuang Liu, Xiaoyin Niu, Yun Shi, Wenfeng Fang, Bing Xiong, Yu Wan, Chen Dong

Get full text

Efficacy and Tolerability of Erlotinib 100 mg/d vs. Gefitinib 250 mg/d in EGFR-Mutated Advanced Non-small Cell Lung Cancer (E100VG250): An Open-Label, Randomized, Phase 2 Study by Shen Zhao, Shen Zhao, Shen Zhao, Zhen Zhang, Zhen Zhang, Zhen Zhang, Zhen Zhang, Wenfeng Fang, Wenfeng Fang, Wenfeng Fang, Yaxiong Zhang, Yaxiong Zhang, Yaxiong Zhang, Zhonghan Zhang, Zhonghan Zhang, Zhonghan Zhang, Shaodong Hong, Shaodong Hong, Shaodong Hong, Yuxiang Ma, Yuxiang Ma, Yuxiang Ma, Ting Zhou, Ting Zhou, Ting Zhou, Yunpeng Yang, Yunpeng Yang, Yunpeng Yang, Yan Huang, Yan Huang, Yan Huang, Hongyun Zhao, Hongyun Zhao, Hongyun Zhao, Li Zhang, Li Zhang, Li Zhang

Get full text

Trends in pain undertreatment among lung cancer patients at the EOL: Analysis of urban city medical insurance data in China by Jiani Zheng, Yihua Huang, Junyi He, Huaqiang Zhou, Tingting Liu, Jie Huang, Mengting Shi, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Li Zhang

Get full text

Anti‐epidermal growth factor receptor monoclonal antibody plus palliative chemotherapy as a first‐line treatment for recurrent or metastatic nasopharyngeal carcinoma by Chen Chen, Yixin Zhou, Xuanye Zhang, Sha Fu, Zuan Lin, Wenfeng Fang, Yunpeng Yang, Yan Huang, Hongyun Zhao, Shaodong Hong, Li Zhang

Get full text

Patients with exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lu... by Yaxiong Zhang, Jin Sheng, Shiyang Kang, Wenfeng Fang, Yue Yan, Zhihuang Hu, Shaodong Hong, Xuan Wu, Tao Qin, Wenhua Liang, Li Zhang

Get full text

TMBserval: a statistical explainable learning model reveals weighted tumor mutation burden better categorizing therapeutic benefits by Yixuan Wang, Jiayin Wang, Wenfeng Fang, Xiao Xiao, Quan Wang, Jian Zhao, Jingjing Liu, Shuanying Yang, Yuqian Liu, Xin Lai, Xiaofeng Song

Get full text

A bibliometric analysis of cerebral palsy from 2003 to 2022 by Yue Hu, Yadan Zheng, Yue Yang, Wenfeng Fang, Maomao Huang, Dan Li, Zhangyu Xu, Fangyuan Xu, Jianxiong Wang, Jianxiong Wang, Jianxiong Wang

Get full text

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer by Teng Li, Han Wang, Jiachen Xu, Chengcheng Li, Yudong Zhang, Guoqiang Wang, Yutao Liu, Shangli Cai, Wenfeng Fang, Junling Li, Zhijie Wang

Get full text

EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients by Qiufan Zheng, Shaodong Hong, Yan Huang, Hongyun Zhao, Yunpeng Yang, Xue Hou, Yuanyuan Zhao, Yuxiang Ma, Ting Zhou, Yaxiong Zhang, Wenfeng Fang, Li Zhang

Get full text